Contribution of Drug Induced Sleep Endoscopy of Pediatric Obstructive Sleep Apnea Hypopnea Syndrome

Contribution of Drug Induced Sleep Endoscopy in the Management of Pediatric Obstructive Sleep Apnea Hypopnea Syndrome

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03845062

Acronym

ESSI

Enrollment

Registered

2019-02-19

Start date

2015-10-01

Completion date

2018-08-01

Last updated

2019-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea Hypopnea Syndrome

Keywords

drug-induced sleep endoscopy, pediatric obstructive sleep apnea hypopnea syndrome, tongue base, epiglottis, occult laryngomalacia, lingual tonsillectomy, epiglottopexy, aryepiglottic folds division

Brief summary

The role of drug-induced sleep endoscopy (DISE) in the management of obstructive sleep apnea hypopnea syndrome (OSAHS) is not precisely defined for children. The primary objective of this study was to describe the consequences of DISE in the therapeutic management for children with OSAHS. The secondary objectives were to analyze the correlation between the number of obstructive sites found during DISE, the value of apnea-hypopnea index (AHI), and the type of OSAHS.

Detailed description

Retrospective single center study of 31 children (mean age: 5.5 ± 2.6 years) who benefited from DISE between 2015 and 2018 in the management of OSAHS. Modification of therapeutic management was noted. A correlation between the number of obstructive sites and the IAH on the one hand, and between the number of obstructive sites and the type of SAHOS on the other hand, was sought.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 12 Years

Healthy volunteers

Inclusion criteria

\- OSAHS confirmed by overnight sleep monitoring (respiratory polygraphy or overnight polysomnography)

Exclusion criteria

\- Lack of data

Design outcomes

Primary

Measure	Time frame	Description
sleep endoscopy	1 day	describe the modification of therapeutic management induced by sleep endoscopy

Secondary

Measure	Time frame	Description
Number of obstructive site during	1 day	retrospective data collection : Number of obstructive site during
value of apnea-hypopnea index	1 day	retrospective data collection : value of apnea-hypopnea index
type obstructive hypopnoea apnea syndrome of sleep	1 day	type obstructive hypopnoea apnea syndrome of sleep. Children facing craniofacial or neuromuscular disorders were rated in Type III OSAHS. Obese children were rated in Type II OSAHS. Others children were rated by default in Type I OSAHS.

Countries

France

Outcome results